Aplisol Related Published Studies
Well-designed clinical trials related to Aplisol (Tuberculin)
The effect of tuberculin testing on the development of cell-mediated immune responses during Mycobacterium bovis infection. [2006.11.15]
The effect of Johne's vaccination on tuberculin testing in farmed red deer (Cervus elaphus). [2005.08]
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? [2003.06.20]
Effect of zinc on the tuberculin response of children exposed to adults with smear-positive tuberculosis. [2002.12]
BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. [2001.11.12]
Comparing the adrenaline-Pirquet test with international PPD tuberculin tests. [2001.03]
A paired comparison of tuberculin skin test results in health care workers using 5 TU and 10 TU tuberculin. [2000.08]
Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standards. [2000.04]
Instrumental measurement of the Mantoux test: differential effects of tuberculin and sodium lauryl sulphate on impedance response patterns in human skin. [2000]
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. [1999.01.13]
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. [1998.12]
Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine. [1998.07]
Performance evaluation of tests used for tuberculin screening in adults: randomised comparison between Tine and Mono. [1998.06]
Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. [1997.09]
Use of automated reminders for tuberculin skin test return. [1997.05]
Comparative tuberculin reactivity to two protein derivatives. [1996.09]
The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma. [1996.02]
Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781). [1996]
Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity. [1995.06]
Can topical zinc accentuate tuberculin reactivity in the elderly? [1994.01]
Skin barrier function and dermal inflammation. An experimental study of transepidermal water loss after dermal tuberculin injection compared with SLS patch testing. [1993.11]
Topically applied verapamil hydrochloride inhibits tuberculin-induced delayed-type hypersensitivity reactions in human skin. [1992.12]
The role of inexperience in measuring tuberculin skin reaction (Mantoux test) by the pen or palpation technique. [1992.05]
Cimetidine as modulator of the cell-mediated immune response in vivo using the tuberculin skin test as parameter. [1990.02]
Lymphocyte proliferation in AIDS-related complex/Walter-Reed 5 patients: response to herpes simplex virus and tuberculin antigen and mitogen during intravenous immunoglobulin treatment. The ARC-IVIG Study Group. [1990]
Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin. [1989.08]
Rifampicin does not suppress the tuberculin reaction in man. [1987.11]
Well-designed clinical trials possibly related to Aplisol (Tuberculin)
Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis. [2009.02.23]
The effect of selenium supplementation on DTH skin responses in healthy North American men. [2009]
The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. [2008.12]
Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes. [2008.11]
Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. [2008.09]
Exercise training enhances in vivo tuberculosis purified protein derivative response in the elderly. [2008.06]
Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. [2007.10]
Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. [2007.07.15]
Zinc cream and reliability of tuberculosis skin testing. [2007.07]
Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial. [2007.05.05]
Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children. [2007.02]
The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi. [2006.12]
Vitamin A supplementation increases ratios of proinflammatory to anti-inflammatory cytokine responses in pregnancy and lactation. [2006.06]
Prostaglandin E1 attenuates impairment of cellular immunity after cardiopulmonary bypass. [2006.04]
Influence of Bacillus Calmette-Guerin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell]. [2005.12]
Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. [2005.11]
Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity. [2005.05]
Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU. [2005.03]
Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? [2005.03]
INH preventive therapy among adult HIV-infected patients in Thailand. [2005.03]
Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. [2005.03]
Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles. [2004.06]
Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle. [2003.11.15]
High-dose inhaled fluticasone and delayed hypersensitivity skin testing. [2003.04]
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. [2003.03]
Comparison of two needle sizes for subcutaneous administration of enoxaparin: effects on size of hematomas and pain on injection. [2002.09]
Immunotherapy with Mycobacterium vaccae and peripheral blood flow in long-treated leprosy patients, a randomised, placebo-controlled trial. [2002.09]
CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment. [2002.08.01]
Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. [2002.06]
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. [2002.04.20]
Collaboration with school nurses: improving the effectiveness of tuberculosis screening. [2001.12]
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. [2001.11.09]
Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. [2001.08.01]
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. [2001.06.01]
Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. [2001.02]
[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group] [2000.07.01]
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. [2000.03.15]
Infant BCG vaccination study in Lithuania. [1999.11]
Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method. [1999.09]
Safety and effectiveness of BCG vaccination in preterm babies. [1999.07]
Clinical reactogenicity of intradermal bacille Calmette-Guerin vaccination. [1999.04]
Monetary versus nonmonetary incentives for TB skin test reading among drug users. [1999.04]
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. [1999.03.11]
Comparison of the safety and immunogenicity of the lyophilized Merieux seed and the World Health Organization working reference BCG vaccines in school-aged children in Senegal. [1999.01]
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. [1998.12.24]
[Comparative study of the efficacy of two types of BCG vaccines administered in different doses] [1998.09]
Tuberculosis screening and compliance with return for skin test reading among active drug users. [1998.05]
The use of tetanus toxoid to elucidate the delayed-type hypersensitivity response in an older, immunized population. [1998]
A 14-mo zinc-supplementation trial in apparently healthy Chilean preschool children. [1997.12]
Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. [1997.10]
Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults. [1997.10]
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. [1997.09.18]
Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy. [1997.09]
Strategies to increase adherence with tuberculosis test reading in a high-risk population. [1997.08]
Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. [1997.06]
Mantoux (tuberculosis) testing. Evaluation of guidelines for testing in Canadian institutions. [1997.05]
Effect of human newborn BCG immunization on monocyte viability and function at 3 months of age. [1997.04]
Effect of early vitamin A supplementation on cell-mediated immunity in infants younger than 6 mo. [1997.01]
BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD. [1996.10]
Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens. [1996.07]
Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guerin. [1996.07]
Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration. [1996.06]
Lack of usefulness of radiographic screening for pulmonary disease in asymptomatic HIV-infected adults. Pulmonary Complications of HIV Infection Study Group. [1996.01.22]
Humoral immune response in infants after BCG vaccination. [1995.06]
[Observation of immune effect of 5 kinds of Denmark II lyophilized vaccines] [1995.02]
[Clinical findings and follow-up of 100 each HIV-negative and HIV-positive cases of bacillary pulmonary tuberculosis in Rwanda] [1995.01]
Influence of needle gauge in Mantoux skin testing. [1994.11]
[Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project] [1994.10]
A single 210-mumol oral dose of retinol does not enhance the immune response in children with measles. [1994.09]
Providing medical care to methadone clinic patients: referral vs on-site care. [1994.02]
Lymphocyte responsiveness of children supplemented with vitamin A and zinc. [1993.10]
Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study. [1993.09.15]
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. [1993.07.31]
Evaluation of the efficacy of health education on the compliance with antituberculosis chemoprophylaxis in school children. A randomized clinical trial. [1993.02]
|
